Active Surveillance

What is Active Surveillance?

  • Involves close monitoring of small, slow-growing prostate cancer with relatively normal-looking cells (as determined by your biopsy results);
  • May be appropriate if you are an older man who may be more likely to develop other (age-related) conditions that may have a greater impact on your health;
  • Doesn’t involve invasive procedures
  • Doesn’t involve drugs
  • No side effects
Your prostate cancer will be monitored closely and may involve the following procedures:
 
  • Regular PSA tests and digital rectal exams
  • Monitoring PSA doubling time (this may mean having a PSA test done every 3-6 months)
    • PSA doubling time refers to how long it takes for a man’s level of prostate-specific antigen to double
  • Occasional repeat biopsies
  • Follow-up bone scan and/or CT scan to monitor disease progression
You will be offered more aggressive treatment at the first sign your prostate cancer has progressed or tumour has grown. Your doctor will discuss the advantages and disadvantages of each treatment option.  You should know that active surveillance is not a cure for prostate cancer.  It also carries the risk that your prostate cancer might spread (metastasize).  This is why regular monitoring is so important. 

You may have heard of the term “watchful waiting”.  Watchful waiting involves having no treatment for your prostate cancer.  Rather than treating the prostate cancer, your doctor will wait until you start having symptoms and treat those, usually with medication. The goal of watchful waiting is not to cure your prostate cancer, but treat your symptoms to make you feel better.
 

For more information and support:





Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada encouraged by growing political support for PSA test coverage in BC

Vancouver BC - April 11, 2017 - Prostate Cancer Canada (PCC) applauds the first provincial party in BC to announce their commitment to cover the cost of PSA (prostate-specific antigen) tests for men when ordered by a physician.
More

Taking fundraising to new heights: Canadians climb 5,000 feet for prostate cancer research

Toronto, ON - March 9, 2017 - Over the course of the last few weeks, corporate teams located in Vancouver, Calgary and Toronto raised more than $650,000 for prostate cancer research by competing in Prostate Cancer Canada’s (PCC) 4th annual Step Up Challenge, presented by Scotiabank.
More

Prostate Cancer Canada's Rock the Road Raffle sells out for 5th consecutive year

March 1, 2017 – TORONTO, ON – For the fifth year and counting, Prostate Cancer Canada’s (PCC) Rock the Road Raffle brought together Ontarians from all walks of life to both support an important cause and have a chance to win a one-of-a-kind dream car.
More


Click here for news archive